Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSaint John's Cancer Institute

About this trial

This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) during breast-conserving surgery. The purpose of this study is to further validate the long-term effectiveness and safety of this treatment method. We aim to assess short and long-term patient outcomes associated with IORT, including perioperative complications, local and distance disease recurrences, as well as disease-free survival and overall survival.

Eligibility criteria

Qualifiers

Clinical stage Tis, T1, or T2(≤ 3cm), N0, M0 (AJCC Classification)

Unifocal Disease

Candidate for breast-conserving surgery

Recommended treatment by multidisciplinary team

Disqualifiers

Clinical stage T3-4, N1-3, M1

Multifocal disease

Trial design

Treatments tested in this trial

  • Intraoperative Radiation Therapy (IORT)

Treatment groups

1,000 Participants
are divided into 1 treatment group

Sponsors and collaborators